Review

Published on 20 Mar 2024

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma

in Neuro-Oncology and Neurosurgical Oncology

Johannes Pöhlmann
Michael Weller
Andrea Marcellusi
Kristin Grabe-Heyne
Lucia Krott-Coi
Silvia Rabar
Richard F. Pollock

Frontiers in Oncology

doi 10.3389/fonc.2024.1368606

3,877 views
2 citations

Original Research

Published on 20 Mar 2024

Tumor treating fields in glioblastoma: long-term treatment and high compliance as favorable prognostic factors

in Neuro-Oncology and Neurosurgical Oncology

Junjie Wang
Quan Du
Jiarui Chen
Jianjian Liu
Zhaowen Gu
Xiaoyu Wang
Anke Zhang
Shiqi Gao
Anwen Shao
Jianmin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1345190

1,248 views

Original Research

Published on 15 Mar 2024

Single brain metastases – prognostic factors and impact of residual tumor burden on overall survival

in Neuro-Oncology and Neurosurgical Oncology

Lea Baumgart
Aida Anetsberger
Amir Kaywan Aftahy
Benedikt Wiestler
Denise Bernhardt
Stephanie E. Combs
Hanno S. Meyer
Gerhard Schneider
Bernhard Meyer
Jens Gempt

Frontiers in Oncology

doi 10.3389/fonc.2024.1330492

1,434 views

Case Report

Published on 13 Mar 2024

Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management

in Neuro-Oncology and Neurosurgical Oncology

Brandon Edelbach
Vadim Gospodarev
Miguel Lopez-Gonzalez
Jeremy Deisch
Maninder Kaur

Frontiers in Oncology

doi 10.3389/fonc.2024.1279897

1,011 views

Case Report

Published on 12 Mar 2024

Hemophagocytic lymphohistiocytosis during treatment of intracranial multifocal germinoma: a case report and literature review

in Neuro-Oncology and Neurosurgical Oncology

Ting Guo
Zichun Liu
Yixin Chen
Yangyang Cheng
Kaitong He
Xin Lin
Mingzhu Wang
Yihua Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1264926

1,192 views
1 citation

Original Research

Published on 11 Mar 2024

A dynamic study of VEGF-A siDOX-EVs trafficking through the in-vitro insert co-culture blood-brain barrier model by digital holographic microscopy

in Neuro-Oncology and Neurosurgical Oncology

Parisa Shamshiripour
Mehrana Rahnama
Mehdi Nikoobakht
Fahimeh Hajiahmadi
Ali-reza Moradi
Davoud Ahmadvand

Frontiers in Oncology

doi 10.3389/fonc.2024.1292083

1,351 views

Editorial

Published on 05 Mar 2024

Editorial: Tumor accommodation: the importance of the niche in neurological tumors

in Neuro-Oncology and Neurosurgical Oncology

Roberta Azzarelli
Laurent R. Gauthier
Jose R. Pineda
Maria Angeles Marques-Torrejon

Frontiers in Oncology

doi 10.3389/fonc.2024.1383594

687 views

Original Research

Published on 22 Feb 2024

DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma

in Neuro-Oncology and Neurosurgical Oncology

Georges Chehade
Nady El Hajj
Mohamed Aittaleb
Maisa I. Alkailani
Yosra Bejaoui
Asma Mahdi
Arwa A. H. Aldaalis
Michael Verbiest
Julie Lelotte
Nuria Ruiz-Reig

Frontiers in Oncology

doi 10.3389/fonc.2024.1359652

1,448 views

Systematic Review

Published on 14 Feb 2024

Radiomics for differentiation of gliomas from primary central nervous system lymphomas: a systematic review and meta-analysis

in Neuro-Oncology and Neurosurgical Oncology

Alexandru Garaba
Nummra Aslam
Francesco Ponzio
Pier Paolo Panciani
Waleed Brinjikji
Marco Fontanella
Lucio De Maria

Frontiers in Oncology

doi 10.3389/fonc.2024.1291861

1,430 views
1 citation

Correction

Published on 13 Feb 2024

Corrigendum: Clinical feasibility of miniaturized Lissajous scanning confocal laser endomicroscopy for indocyanine green-enhanced brain tumor diagnosis

in Neuro-Oncology and Neurosurgical Oncology

Duk Hyun Hong
Jang Hun Kim
Jae-Kyung Won
Hyungsin Kim
Chayeon Kim
Kyung-Jae Park
Kyungmin Hwang
Ki-Hun Jeong
Shin-Hyuk Kang

Frontiers in Oncology

doi 10.3389/fonc.2024.1375620

633 views

Correction

Published on 01 Feb 2024

Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

in Neuro-Oncology and Neurosurgical Oncology

Barbara Castelli
Carla Fonte
Milena Guidi
Marco Tellini
Marco Di Nicola
Alessandro Iacono
Anna Maria Buccoliero
Daniela Greto
Lorenzo Genitori
Iacopo Sardi

Frontiers in Oncology

doi 10.3389/fonc.2024.1372295

968 views

Original Research

Published on 31 Jan 2024

Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells

in Neuro-Oncology and Neurosurgical Oncology

Remi Weber
Michael Weller
Guido Reifenberger
Flavio Vasella

Frontiers in Oncology

doi 10.3389/fonc.2024.1342114

1,668 views

Original Research

Published on 30 Jan 2024

Enhancing the referral process for surgical management of spinal metastases: insights from a 12-year, bi-institutional study of 533 patients

in Neuro-Oncology and Neurosurgical Oncology

Bertrand Debono
Alexis Perez
Guillaume Lonjon
Olivier Hamel
Jean-Baptiste Dandine
Martin Dupuy
Guillaume Dutertre
Cécile Braticevic
Igor Latorzeff
Aymeric Amelot

Frontiers in Oncology

doi 10.3389/fonc.2024.1301305

875 views

Original Research

Published on 29 Jan 2024

Robotic stereotactic radiosurgery for intracranial meningiomas in elderly patients: assessment of treatment efficacy and safety

in Neuro-Oncology and Neurosurgical Oncology

Anton Früh
Bohdan Bodnar
Marcel Nachbar
Julia Gradhand
Goda Kalinauskaite
Kerstin Rubarth
Peter Truckenmueller
David Kaul
Daniel Zips
Peter Vajkoczy

Frontiers in Oncology

doi 10.3389/fonc.2024.1329696

1,061 views

Case Report

Published on 24 Jan 2024

Case report: Unilateral paralysis of the hypoglossal nerve as the only clinical sign of clivus meningioma - a case report and literature review

in Neuro-Oncology and Neurosurgical Oncology

Jelena Stamenović
Biljana Živadinović
Vanja Đurić

Frontiers in Oncology

doi 10.3389/fonc.2024.1337680

970 views

Original Research

Published on 23 Jan 2024

MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma

in Neuro-Oncology and Neurosurgical Oncology

Jinmin Sun
Sicheng Wu
Wenyu Zhao
Senrui Xue
Lei Zhang
Jing Ren

Frontiers in Oncology

doi 10.3389/fonc.2024.1307992

1,472 views

Navigation group

Articles

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma

Tumor treating fields in glioblastoma: long-term treatment and high compliance as favorable prognostic factors

Single brain metastases – prognostic factors and impact of residual tumor burden on overall survival

Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management

Hemophagocytic lymphohistiocytosis during treatment of intracranial multifocal germinoma: a case report and literature review

A dynamic study of VEGF-A siDOX-EVs trafficking through the in-vitro insert co-culture blood-brain barrier model by digital holographic microscopy

Editorial: Tumor accommodation: the importance of the niche in neurological tumors

DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma

Radiomics for differentiation of gliomas from primary central nervous system lymphomas: a systematic review and meta-analysis

Corrigendum: Clinical feasibility of miniaturized Lissajous scanning confocal laser endomicroscopy for indocyanine green-enhanced brain tumor diagnosis

Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells

Enhancing the referral process for surgical management of spinal metastases: insights from a 12-year, bi-institutional study of 533 patients

Robotic stereotactic radiosurgery for intracranial meningiomas in elderly patients: assessment of treatment efficacy and safety

Case report: Unilateral paralysis of the hypoglossal nerve as the only clinical sign of clivus meningioma - a case report and literature review

MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma